TNF Pharmaceuticals shareholders approve 5x increase in authorized common shares and reverse split authorization

Q/C TECHNOLOGIES, INC.

Authorized common shares increased from 250M to 1.25B, filed June 6, 2025.
Stockholders approved reverse stock split at ratio 1-for-2 to 1-for-100, board discretion, within one year.
Series F and F-1 preferred stock stated value increased from $1,000 to $1,100 per share, board may increase up to $1,250.
All six director nominees elected; auditor ratification approved.
Voting results: ~6.3M for share increase, ~6.4M for reverse split.

item 3.03item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.